In support of the role of hepatocyte apoptosis in advanced liver pathogenesis, it is relevant that cytokeratin-18 (CK-18), a marker of hepatocyte apoptosis, which occurs in NASH but not in NAFLD, is the most validated diagnostic biomarker of NASH. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.